DAY 3 |

  • Additional Featured Videos


Featured Videos

Highlights from the Presenter of Keynote 6, Dr Pratishtha Chatterjee

Convenor of the Australian Dementia Network Forum 2025, Professor Ralph Martins AO

Dr Pratishtha Chatterjee:
Keynote 6: From Research To Reality: How Blood Biomarkers Are Shaping Clinical Practice In Alzheimer’s Disease

  • Chatterjee P, Pedrini S, Ashton NJ, et al. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer’s disease. Alzheimers Dement 2021; 18: 1141–1154. Available here (accessed June 2025).

  • TGA approval of donanemab

  • Quanterix P-tau217 FDA approval

  • SINGER study

  • Comas M, Vidal X, Rawashdeh O, Grunstein RR, Lewis SJG, Matar E. Alterations in sleep-activity cycles and clock gene expression across the synucleinopathy spectrum. Transl Neurodegener 2025; 14: ePub. Available here (accessed June 2025).

  • Anderson J, Chiu NKH, Pye JE, et al. Rest–Activity Disturbances Correlate with Core Features in Dementia with Lewy Bodies. Mov Disord Clin Prac 2025: ePub. Available here (accessed June 2025).

Professor Ralph Martins AO:
Concluding remarks from the Convenor of the conference with discussion of his ongoing research into the role of lifestyle factors in the prevention of Alzheimer’s disease.

  • TGA approval of donanemab

  • Gardener SL, Fuller SJ, Naismith SL, et al. The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU‐ARROW): A study protocol for a single‐blind, multi‐site, randomized controlled trial. Alzheimers Dement 2024; 10: e12466. Available here (accessed June 2025).

Not a registered user of our websites?

Sign up for access here »

This collection of videos is sponsored as an educational service by Eli Lilly Australia Pty Ltd.